Vericel

0 followers

‌

Vericel (NASDAQ:VCEL) develops, manufactures and markets autologous expanded cell therapies for the treatment of patients with serious diseases and conditions

Industries

Biotechnology

Headquarters

Cambridge, United States

Employees

51-200

Links

Org chart

Dominick Colangelo

President & CEO

Dominick Colangelo

Collapse

Joe Mara

CFO

Jonathan Hopper

Chief Medical Officer

Sean Flynn

SVP, General Counsel & Secretary

Mike Halpin

SVP, Quality & Regulatory Affairs

Patrick Fowler

SVP, Corporate Development & Strategy

Roland DeAngelis

SVP, Commercial Operations

Doug Kennedy

SVP, Operations

Heidi Hassen

SVP, Human Resources

Shannon Kelly

VP, Burn Care National Sales

Caryn Crame

VP, Clinical Affairs & Epidemiology

VP, MACI Sales

VP, Manufacturing

VP, Quality

VP, Marketing & Commercial Strategy

Teams

+28

Sales and Marketing

31 members

+12

Clinical and Medical Affairs

15 members

Operations and Development Team

12 members

Quality and Regulatory

9 members

Directors Team

9 members

Finance and Accounting

8 members

Similar companies

Assembly Biosciences

9 followers

REVOLUTION Medicines

5 followers

Summit Therapeutics

4 followers

Viridian Therapeutics

2 followers

Ocugen

1 follower

Truveta

2 followers

Thermo Fisher Scientific

168 followers

Gilead Sciences

129 followers

Biogen

115 followers

Regeneron

95 followers

Illumina

68 followers

Explore companies